Shares of Alamar Biosciences Inc. are expected to begin trading on the Nasdaq Global Select Market, under the ticker symbol "ALMR", on April 17, 2026.
This commercial-stage proteomics company has developed a proprietary NULISA technology to overcome the limitations of traditional proteomics tools, enabling the detection of protein biomarkers at extremely low concentrations using non-invasive biological samples such as blood.
For comments and feedback contact: editorial@rttnews.com
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.